COLOGNE, Germany, March 10, 2015 /PRNewswire/ --
DENTSPLY Implants remains strongly committed to innovation, science and clinical research. Parallel to expanding worldwide, DENTSPLY Implants has continued its dedication to innovation, science and clinical research. The company is now truly global and the commitment to the extensive clinical research program and innovative product launches continues at a very high level-all for improving dental implant patients' quality of life.
(Logo: http://photos.prnewswire.com/prnh/20150310/732980-a )
DENTSPLY Implants was introduced to the dental market three years ago and has rapidly established its own sales organizations all around the world. DENTSPLY Implants has a direct global sales organization with 25 market units and cooperation with exclusive distributors in more than 40 countries all over the world. Close to 95 percent of the current sales are within DENTSPLY Implants' own sales organizations.
An important component in the global expansion was the last year's opening of DENTSPLY Implants in China, a market where ANKYLOS and XiVE implant lines have been present and successful since 1998. The Chinese dental market is growing rapidly, especially the surge of high-end businesses such as dental implants.
"It is really exciting to be part of the development and the growth in this dynamic region. The launch in China has been very successful so far. At the time of the opening we also introduced the ASTRA TECH Implant System to the Chinese market and we have a comprehensive clinical research program at fifteen study centers in China," says Lars Henrikson, Group President DENTSPLY Implants.
Parallel to the introduction in markets all over the world, DENTSPLY Implants has continued its dedication to science and clinical research. The origin of DENTSPLY Implants is based on a solid foundation of over 40 years of expertise, knowledge and experience in all relevant fields and technologies of implant dentistry. DENTSPLY Implants' products and solutions are well documented with reliable clinical results. Documentation is an integrated and essential part of the product development process.
"Our commitment to research and scientifically proven solutions is stronger than ever and DENTSPLY Implants products are supported by more than 1,650 scientific publications. At the moment, we have 200 ongoing studies, currently involving more than 450 clinicians. We are very excited and proud about the new 5-year data on OsseoSpeed implants that shows maintained bone levels from implant placement, confirming an average of only 0.3 mm bone reduction," says AnnaKarin Lundgren, Director Global Scientific Affairs at DENTSPLY Implants.
Another cornerstone of DENTSPLY Implants is the dedication to innovation. Since the introduction, DENTSPLY Implants has continued to launch leading digital solutions by further improving the digital workflow for implant treatment with the highest function and esthetics meeting the demands of dental professionals.
"Our continued success is dependent on how customers and patients experience our products and our service. Our focus is to deliver safe, well-documented solutions and the best service to our customers. An example of this customer focus is the ASTRA TECH Implant System EV, which was developed in close cooperation with our customers. In fact, this launch has been one of the most successful launches in DENTSPLY Implants' history," says Lars Henrikson.
About DENTSPLY Implants
DENTSPLY Implants offers comprehensive solutions for all phases of implant therapy, including ANKYLOS®, ASTRA TECH Implant System'and XiVE®implant lines, digital technologies, such as ATLANTIS'patient-specific CAD/CAM solutions and SIMPLANT®guided surgery, SYMBIOS®regenerative solutions, and professional development programs. DENTSPLY Implants creates value for dental professionals and allows for predictable and lasting implant treatment outcomes, resulting in enhanced quality of life for patients.
About DENTSPLY International
DENTSPLY International Inc. is a leading manufacturer and distributor of dental and other healthcare products. For over 110 years, DENTSPLY's commitment to innovation and professional collaboration has enhanced its portfolio of branded consumables and small equipment. Headquartered in the United States, the Company has global operations with sales in more than 120 countries.
For further information, please contact:Kerstin Wettby, Senior Manager, Global Marketing, Communication & PR, DENTSPLY Implants, Sweden, Cell phone +46-705-16-32-02, kerstin.wettby@dentsply.com , http://www.dentsplyimplants.com
As a member of the press, you can also visit our News & Press Room at:http://www.dentsplyimplants.com/en/Resources/News-and-Press
